Nextage Therapeutics Ltd (TLV:NXTG)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
77.90
+0.40 (0.52%)
At close: Sep 30, 2025
17.14%
Market Cap26.25M
Revenue (ttm)413.00K
Net Income (ttm)-3.28M
Shares Out33.70M
EPS (ttm)-0.10
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume23,330
Average Volume21,299
Open77.50
Previous Close77.50
Day's Range77.50 - 78.00
52-Week Range56.00 - 119.00
Beta0.16
RSI42.14
Earnings DateNov 27, 2025

About Nextage Therapeutics

Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products in Israel and internationally. The company was incorporated in 1982 and is based in Ness Ziona, Israel. [Read more]

Sector Healthcare
Founded 1982
Employees 31
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol NXTG
Full Company Profile

Financial Performance

In 2024, Nextage Therapeutics's revenue was 413,000, a decrease of -52.85% compared to the previous year's 876,000. Losses were -3.28 million, -15.36% less than in 2023.

Financial Statements

News

There is no news available yet.